
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
CORRECTION article
Front. Immunol. , 10 October 2023
Sec. Molecular Innate Immunity
Volume 14 - 2023 | https://doi.org/10.3389/fimmu.2023.1296381
This article is a correction to:
Biological activity of human IgE monoclonal antibodies targeting Der p 2, Fel d 1, Ara h 2 in basophil mediator release assays
A Corrigendum on
Biological activity of human IgE monoclonal antibodies targeting Der p 2, Fel d 1, Ara h 2 in basophil mediator release assays
by Pena-Castellanos G, Smith BRE, Pomés A, Smith SA, Stigler MA, Widauer HL, Versteeg SA, van Ree R, Chapman MD and Aglas L (2023) Front. Immunol. 14:1155613. doi: 10.3389/fimmu.2023.1155613
In the published article, there was an error in Supplementary Table 1. In the originally submitted Supplementary Table 1, the names of the hIgE mAbs specific for the Der p 2 allergen were mixed up. Additionally, the concentrations reported for the total IgE concentrations for the Fel d 1 specific hIgE mAbs in this table were incorrect (these were the concentrations of sIgE found for the Cat dander extract not the total IgE concentration). Total IgE concentrations for any of the hIgE mAbs were not used for any of the experiments and were only included for the sake of completion.
The correct Supplementary Table 1 has been updated in the original article.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: human IgE monoclonal antibodies, mediator release assay, Der p 2, Fel d 1, Ara h 2, allergy diagnosis
Citation: Pena-Castellanos G, Smith BRE, Pomés A, Smith SA, Stigler MA, Widauer HL, Versteeg SA, van Ree R, Chapman MD and Aglas L (2023) Corrigendum: Biological activity of human IgE monoclonal antibodies targeting Der p 2, Fel d 1, Ara h 2 in basophil mediator release assays. Front. Immunol. 14:1296381. doi: 10.3389/fimmu.2023.1296381
Received: 18 September 2023; Accepted: 28 September 2023;
Published: 10 October 2023.
Edited and Reviewed by:
Francesca Granucci, University of Milano-Bicocca, ItalyCopyright © 2023 Pena-Castellanos, Smith, Pomés, Smith, Stigler, Widauer, Versteeg, van Ree, Chapman and Aglas. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Lorenz Aglas, bG9yZW56LmFnbGFzQHBsdXMuYWMuYXQ=
†ORCID: Glorismer Pena-Castellanos, orcid.org/0000-0002-6882-4714
Anna Pomés, orcid.org/0000-0002-8729-1829
Scott A. Smith, orcid.org/0000-0002-5519-8662
Maria A. Stigler, orcid.org/0000-0002-8890-5271
Hannah L. Widauer, orcid.org/0000-0003-0593-7567
Serge A. Versteeg, orcid.org/0000-0002-9729-3000
Ronald van Ree, orcid.org/0000-0003-0767-0894
Martin D. Chapman, orcid.org/0000-0002-0845-3632
Lorenz Aglas, orcid.org/0000-0002-1236-5934
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.